EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Use of mirtazapine in the treatment of canine behaviour problems: A review of 32 cases

Juan Argüelles iD, Blanca Duque, Marina Miralles, Jonathan Bowen, Jaume Fatjo

Veterinary Record · 20.04.2024 · 194 (8)

DOI: 10.1002/vetr.3670 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 11.12.2023. Verfasst von Juan Argüelles und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardenal Herrera-CEU University, Valencia, Spain. Hauptthemen laut MEDLINE: Anti-Anxiety Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ethoclinic Valencia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Canine behaviour problems seen by speciality behavioural medicine services often involve chronic anxiety disorders that have resulted in maladaptation of the individual to its environment. Common stressors include the presence of other individuals (other dogs or people), noise and being alone. The treatment of these behavioural problems usually includes a combination of behaviour modification, environmental modification and biological therapies. Within the latter, anxiolytic drugs such as clomipramine or fluoxetine have proven useful.

Methods

Here, we present a retrospectively analysed series of 32 cases that were treated with the anxiolytic drug mirtazapine, which is widely used in human medicine but has not previously been reported for the treatment of behavioural problems in dogs (although it is marketed as an appetite stimulant in cats). Cases included dogs with a range of anxiety‐related behavioural problems.

Results

Eighty‐one percent of dogs that presented with a behavioural problem showed improvement and suspected adverse effects were mild and tolerable.

Limitations

Further studies are required to isolate this result from the other therapeutic measures and to compare its efficacy with other drugs.

Conclusion

Mirtazapine appears to be a suitable and safe option for the treatment of anxiety‐related behavioural problems in dogs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsAnimalsDogsAnxietyAnxiety DisordersMirtazapineRetrospective StudiesDog Diseases

Substanzen

Anti-Anxiety AgentsMirtazapine

Autor:innen und Institutionen

  • Cardenal Herrera-CEU University, Valencia, Spain.
  • Ethoclinic Valencia, Valencia, Spain.
  • Queen Mother Hospital for Animals, Royal Veterinary College, Hatfield, UK.
  • Chair Affinity Foundation Animals and Health, Department of Psychiatry and Forensic Medicine, Autonomous University of Barcelona, Barcelona, Spain.

ORCID-Profile: Juan Argüelles

Förderung

  • Ethoclinic Valencia

Zitieren

APA

Argüelles, J., Duque, B., Miralles, M., Bowen, J., & Fatjo, J. (2024). Use of mirtazapine in the treatment of canine behaviour problems: A review of 32 cases. Veterinary Record, 194(8). https://doi.org/10.1002/vetr.3670

Vancouver

Argüelles J, Duque B, Miralles M, Bowen J, Fatjo J. Use of mirtazapine in the treatment of canine behaviour problems: A review of 32 cases. Veterinary Record. 2024;194(8). doi:10.1002/vetr.3670

BibTeX
@article{Argelles2024,
  author = {Argüelles, Juan and Duque, Blanca and Miralles, Marina and Bowen, Jonathan and Fatjo, Jaume},
  title = {Use of mirtazapine in the treatment of canine behaviour problems: A review of 32 cases},
  journal = {Veterinary Record},
  year = {2024},
  volume = {194},
  number = {8},
  doi = {10.1002/vetr.3670}
}
Kostenlos starten →